Arrowstreet Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.3M | Buy |
|
|||||
|
2025
Q1 | $6.05M | Sell |
|
|||||
|
2024
Q4 | $12.9M | Sell |
|
|||||
|
2024
Q3 | $251M | Sell |
|
|||||
|
2024
Q2 | $315M | Sell |
|
|||||
|
2024
Q1 | $370M | Sell |
|
|||||
|
2023
Q4 | $679M | Sell |
|
|||||
|
2023
Q3 | $766M | Buy |
|
|||||
|
2023
Q2 | $685M | Buy |
|
|||||
|
2023
Q1 | $680M | Sell |
|
|||||
|
2022
Q4 | $705M | Sell |
|
|||||
|
2022
Q3 | $743M | Sell |
|
|||||
|
2022
Q2 | $968M | Sell |
|
|||||
|
2022
Q1 | $1.07B | Buy |
|
|||||
|
2021
Q4 | $308M | Buy |
|
|||||
|
2021
Q3 | $2.56M | Sell |
|
|||||
|
2021
Q2 | $42.5M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $180M | Buy |
|
|||||
|
2020
Q3 | $135M | Buy |
|
|||||
|
2020
Q2 | $152M | Buy |
|
|||||
|
2020
Q1 | $82.2M | Sell |
|
|||||
|
2019
Q4 | $116M | Buy |
|
|||||
|
2019
Q3 | $113M | Sell |
|
|||||
|
2019
Q2 | $243M | Buy |
|
|||||
|
2019
Q1 | $211M | Buy |
|
|||||
|
2018
Q4 | $73.8M | Sell |
|
|||||
|
2018
Q3 | $103M | Sell |
|
|||||
|
2018
Q2 | $178M | Sell |
|
|||||
|
2018
Q1 | $239M | Buy |
|
|||||
|
2017
Q4 | $220M | Buy |
|
|||||
|
2017
Q3 | $1.97M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $58.7M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.14M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $38M | Buy |
|
|||||
|
2015
Q4 | $40.7M | Buy |
|
|||||
|
2015
Q3 | $9.41M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $212M | Buy |
|
|||||
|
2014
Q3 | $228M | Buy |
|
|||||
|
2014
Q2 | $27.6M | Sell |
|
|||||
|
2014
Q1 | $249M | Buy |
|
|||||
|
2013
Q4 | $235M | Buy |
|
|||||
|
2013
Q3 | $162M | Buy |
|
|||||
|
2013
Q2 | $77.2M | Buy |
|